| Financial Year |
March 31 2023 |
| Monetary Funds |
93,752,815.69 |
| Held-for-trading Financial Assets |
408,180,120.18 |
| Notes Receivable |
58,694,162.97 |
| Accounts Receivable |
157,708,638.76 |
| Advances to Suppliers |
5,978,668.46 |
| Other Receivables |
19,229,666.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
87,693,510.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
893,818,265.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
171,679,899.81 |
| Under-construction Projects |
47,500.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
40,712,806.20 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
872,233.53 |
| Deferred Income Tax Assets |
5,200,155.08 |
| Other Non-Current Assets |
1,857,922.05 |
| Sub-Total of Non-Current Assets |
289,289,434.81 |
| Total Assets |
1,183,107,700.22 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
27,782,166.58 |
| Accounts Payable |
94,990,882.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,004,212.06 |
| Taxes Payable |
6,458,847.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,107,767.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
230,257.18 |
| Other Current Liabilities |
18,790,212.13 |
| Sub-Total of Current Liabilities |
171,917,582.06 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,786,356.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,988,600.10 |
| Total Liabilities |
182,906,182.16 |
| Paid-In Capital(Or Share Stock) |
291,990,440.00 |
| Capital Surplus |
253,978,897.57 |
| Surplus Reserve |
76,828,103.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
313,096,220.44 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,000,201,518.06 |
| Owner's Equity（Stockholder's Equity） |
1,000,201,518.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,183,107,700.22 |
